Tech Company Financing Transactions
Diartis Pharmaceuticals Funding Round
Index Ventures and private investors participated in a capital raise for Diartis Pharmaceuticals. The financing was announced on 2/16/2011.
Transaction Overview
Company Name
Announced On
2/16/2011
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Index Ventures (Kevin Johnson)
Proceeds Purpose
The company will focus on moving this exciting compound rapidly through early clinical development. Given the dramatic rise in the number of people with type 2 diabetes, there is a significant market need for a longer acting form of the GLP-1 analog exenatide.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
275 Shoreline Dr. 450
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Overview
Diartis Pharmaceuticals, Inc. is a privately held biopharmaceutical company with headquarters in Mountain View, CA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Cleland
Browse more venture capital transactions:
Prev: 2/15/2011: Control4 venture capital transaction
Next: 2/16/2011: ecoATM venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs